Isoproterenol (injection)

Revision as of 01:28, 4 September 2012 by C Michael Gibson (talk | contribs)
Jump to navigation Jump to search
Isoproterenol (injection)
Clinical data
Routes of
administration
inhaled 80-120μg
ATC code
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC11H17NO3
Molar mass211.258 g/mol

WikiDoc Resources for Isoproterenol (injection)

Articles

Most recent articles on Isoproterenol (injection)

Most cited articles on Isoproterenol (injection)

Review articles on Isoproterenol (injection)

Articles on Isoproterenol (injection) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Isoproterenol (injection)

Images of Isoproterenol (injection)

Photos of Isoproterenol (injection)

Podcasts & MP3s on Isoproterenol (injection)

Videos on Isoproterenol (injection)

Evidence Based Medicine

Cochrane Collaboration on Isoproterenol (injection)

Bandolier on Isoproterenol (injection)

TRIP on Isoproterenol (injection)

Clinical Trials

Ongoing Trials on Isoproterenol (injection) at Clinical Trials.gov

Trial results on Isoproterenol (injection)

Clinical Trials on Isoproterenol (injection) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Isoproterenol (injection)

NICE Guidance on Isoproterenol (injection)

NHS PRODIGY Guidance

FDA on Isoproterenol (injection)

CDC on Isoproterenol (injection)

Books

Books on Isoproterenol (injection)

News

Isoproterenol (injection) in the news

Be alerted to news on Isoproterenol (injection)

News trends on Isoproterenol (injection)

Commentary

Blogs on Isoproterenol (injection)

Definitions

Definitions of Isoproterenol (injection)

Patient Resources / Community

Patient resources on Isoproterenol (injection)

Discussion groups on Isoproterenol (injection)

Patient Handouts on Isoproterenol (injection)

Directions to Hospitals Treating Isoproterenol (injection)

Risk calculators and risk factors for Isoproterenol (injection)

Healthcare Provider Resources

Symptoms of Isoproterenol (injection)

Causes & Risk Factors for Isoproterenol (injection)

Diagnostic studies for Isoproterenol (injection)

Treatment of Isoproterenol (injection)

Continuing Medical Education (CME)

CME Programs on Isoproterenol (injection)

International

Isoproterenol (injection) en Espanol

Isoproterenol (injection) en Francais

Business

Isoproterenol (injection) in the Marketplace

Patents on Isoproterenol (injection)

Experimental / Informatics

List of terms related to Isoproterenol (injection)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Isoproterenol hydrochloride or isoprenaline (Medihaler-Iso®) is a sympathomimetic beta adrenergic receptor agonist medication.

It is structurally similar to epinephrine but acts for the most part on beta receptors.

Uses

It is used as an inhaled aerosol to treat asthma. Although it activates all beta adrenergic receptors, it works in a similar fashion to the more selective beta2-adrenergic receptor agonists e.g. salbutamol, by relaxing the airways to increase airflow.

It is also supplied in ampules under the brand name Isuprel® for injection and in sublingual pill form for treatment of asthma, chronic bronchitis and emphysema.

Used with caution, it can also be used to treat torsades de pointes, in conjunction with overdrive pacing and magnesium.

Pharmacology

Isoproterenol is a β1- and β2-adrenoceptor agonist which was commonly used to treat asthma before the more widespread use of salbutamol, which has more selective effects on the airways. Its route of administration is either intravenous, oral, intranasal, subcutaneous, or intramuscular, depending on use. The plasma half-life for isoproterenol is approximately two hours.

Isoproterenol's effects on the cardiovascular system relate to its actions on cardiac β1 receptors and β2 receptors on skeletal muscle arterioles. Isoproterenol has positive inotropic and chronotropic effects on the heart. In skeletal muscle arterioles it produces vasodilatation. Its inotropic and chronotropic effects elevate systolic blood pressure, while its vasodilatory effects tend to lower diastolic blood pressure.

The adverse effects of isoproterenol are also related to the drug's cardiovascular effects. Isoproterenol can produce an elevated heart rate (tachycardia), which predisposes patients to cardiac dysrhythmias.

Warnings and Contraindications

Isoproterenol should not be administered to patients with myocardial ischaemia.

Template:Adrenergic and dopaminergic agents

de:Isoprenalin it:Isoprotenerolo sk:Izoprenalín


Template:WikiDoc Sources